Community-acquired pneumonia (CAP) 
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in accordance with the guidelines. However, the committee identified a number of issues to be addressed in guideline updates including criteria for physiological assessment, the handling of cases in which physical findings and laboratory test results are not in agreement, age-related issues (especially the treatment of patients over the age of 65), the differentiation between bacterial pneumonia and atypical pneumonia, the weighing of underlying diseases and complications, and guidelines regarding the use of adjuvant therapy (20). The committee decided that an update should be provided every three years so that important developments can be highlighted and pressing questions can be answered. Therefore, it has been revising them since December 2003 and updated them in October 2005 (21). The major and important changes have been in the recommendations for severity assessment, the initial site of treatment decision, microbiological investigation including the urinary antigen test, clinical differentiation of atypical pneumonia and antibiotics selection including newer drugs. A summary of the updated and new recommendations in the JRS guidelines is given in
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Etiology and antimicrobial resistance

During the past five years, many researchers have been carrying out studies on CAP etiologies and antimicrobial resistance in Japan and the number of findings is growing every year. As for epidemiological studies, a multi-center CAP surveillance has been performed in seven medical schools and their affiliate hospitals (Saito A, in preparation). The results of this study together with other prospective studies have demonstrated that Streptococcus pneumoniae and atypical pathogens including the Mycoplasma pneumoniae and Chlamydia pneumoniae are common pathogens (Table 2) (22-25). In addition, a prospective study of CAP etiology has been performed in an ambulatory setting for the first time in Japan (Fig. 1) (25). The results indicated that the incidence of infection caused by two atypical pathogens, M. pneumoniae and C. pneumoniae, was higher among outpatients than among hospitalized patients. A lower incidence of bacteria, especially S. pneumoniae, may be related to the younger age of the patients, a low incidence of comorbidities and the limitations of the tests performed. A multicenter study in an ambulatory setting is necessary. The etiologic agent which is most clearly differentiated between Japan and Western countries is the frequency of drug-resistant S. pneumoniae (26-28). A recent study found that the frequency of penicillin-resistant and macrolideresistant S. pneumoniae has been increasing gradually in Japan (26). Furthermore, approximately half of S. pneumoniae cases show strong resistance to macrolides with minimum inhibitory concentrations (MICs) greater than or equal to 256 μg/mL
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age-related issues (< 65 years old) and the weighing of underlying diseases and complications (20, 42, 43). In addition, we found no correlations between the severity of CAP and some features of severity assessment in the JRS guidelines such as C-reactive protein values. Therefore, the guideline committee needed to make a major revision in severity assessment and changed to a simple score which is a modified version of the CURB-65 score based on Japanese situations (Fig. 2). The reason for selection of this assessment
Treatment algorithm and recommendations for antimicrobial therapy
The JRS guidelines seek to address the management of CAP according to disease severity; Fig. 4 
